Keyword Connections

remdesivir

Journals

8

1 current medicinal chemistry

2 Cureus

3 Journal of biomolecular structure & dynamics

4 The FEBS Journal

5 Antiviral research

6 pharmacotherapy

7 Journal of neural transmission (Vienna, Austria : 1996)

8 drugs in context

Research Groups

0

No Research Group Connected

Bibliographies

15

1 Identification of Chymotrypsin-like Protease Inhibitors of SARS-CoV-2 Integrated Computational Approach.

2 Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.

3 SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus.

4 Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2.

5 Remdesivir: Review of pharmacology, pre-clinical data and emerging clinical experience for COVID-19.

6 A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.

7 The journey of remdesivir: from Ebola to COVID-19.

8 Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients

9 Remdesivir shifts circadian rhythmicity to eveningness; similar to the most prevalent chronotype in ADHD.

10 Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.

11 Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

12 Structural basis of potential binding mechanism of remdesivir to SARS-CoV-2 RNA dependent RNA polymerase.

13 A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir

14 Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study

15 1′-Ribose cyano substitution allows Remdesivir to effectively inhibit nucleotide addition and proofreading during SARS-CoV-2 viral RNA replication